Global High-Priority Regulatory Events — January 29, 2026

30-01-2026

30-01-2026

30-01-2026

30-01-2026

30-01-2026

30-01-2026

30-01-2026

30-01-2026

30-01-2026

Civitas Resources, Inc. disclosed in its 8-K filing on 2026-01-30 the completion of an acquisition or disposition of assets (Item 2.01) and termination of a material definitive agreement (Item 1.02), alongside notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures/elections of directors and officers (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). While the transaction completion may realize value for target stakeholders, the delisting and changes in control introduce significant negative implications including reduced liquidity and altered governance. No financial metrics, deal values, or specific parties were disclosed.

30-01-2026

30-01-2026

30-01-2026

30-01-2026

30-01-2026

QuantumScape Corp filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for change, or any quantitative data such as compensation amounts are disclosed. No positive or negative metrics, financial impacts, or governance implications are mentioned.

30-01-2026

SunPower Inc. filed a Form 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 3.02 unregistered sales of equity securities, with Item 9.01 for financial statements and exhibits. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, terms, or financial impacts provided. No positive or negative metrics, period-over-period changes, or strategic context were disclosed.

30-01-2026

Brand Engagement Network Inc. filed a multi-item 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02, with additional other events under Item 8.01. While the material agreement may signal strategic funding or partnership opportunities, the new financial obligation introduces potential debt risks and the equity sales raise shareholder dilution concerns. No quantitative details such as transaction values, share counts, or financial impacts were disclosed.

30-01-2026

ESS Tech, Inc. filed an 8-K on 2026-01-30 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, financial impacts, or other metrics are disclosed. AccNo: 0001628280-26-004263; File Size: 1 MB.

• ·Sector: not specified
• ·Source: us_sec
• ·File Size: 1 MB
• ·Multi-item filing: Yes (Items 1.01 and 9.01)
• ·Mandatory disclosure under SEC 8-K rules for Item 1.01

30-01-2026

GRI Bio, Inc. filed an 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details, financial metrics, transaction values, positive or negative changes, or other quantitative data are disclosed.

30-01-2026

Bluejay Diagnostics, Inc. filed a Form 8-K on January 30, 2026, disclosing events under multiple items including Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing appears related to governance changes and shareholder vote outcomes, but no specific details on the nature of modifications, vote results, or financial impacts are provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

30-01-2026

Lake Superior Acquisition Corp filed an 8-K on 2026-01-30 announcing under Item 1.01 entry into a material definitive agreement related to a merger/acquisition event. Item 9.01 discloses financial statements and exhibits, likely including pro forma information and the agreement itself. No specific transaction terms, financial metrics, parties beyond the filer, valuations, synergies, or impacts are detailed in the provided filing summary.

30-01-2026

Twin Hospitality Group Inc. filed a Form 8-K on 2026-01-30 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, guidance changes, or other quantitative details are disclosed. Sector is not specified.

• ·Accession Number: 0001493152-26-004291
• ·Filing size: 212 KB

30-01-2026

Flag Ship Acquisition Corp filed an 8-K on January 30, 2026, disclosing under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 includes financial statements and exhibits. No specific details on parties, amounts, terms, or context such as merger financing are provided.

30-01-2026

RICHTECH ROBOTICS INC. filed an 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. Item 8.01 reports other events, accompanied by financial statements and exhibits under Item 9.01. No specific transaction values, share counts, financial impacts, or detailed terms are disclosed.

30-01-2026

Fat Brands, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004289), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing from the US market. No additional financial metrics, reasons for delisting, dollar values, or impacts were disclosed. This event signals a material regulatory compliance failure with no offsetting positive developments mentioned.

30-01-2026

Constellation Acquisition Corp I filed an 8-K on January 30, 2026, disclosing under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 5.07 submission of matters to a vote of security holders, and under Item 9.01 financial statements and exhibits. No quantitative metrics, deal values, financial impacts, or specific transaction details are provided in the filing excerpt. No positive or negative performance metrics are mentioned.

30-01-2026

30-01-2026

30-01-2026

Winvest Group Ltd filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed. No positive or negative metrics are mentioned.

30-01-2026

Designer Brands Inc. filed a Form 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative data such as compensation amounts are disclosed in the provided filing information. No financial metrics, performance comparisons, or other impacts are mentioned.

30-01-2026

Immunocore Holdings plc filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed.

30-01-2026

CHOICEONE FINANCIAL SERVICES INC filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-030504, Size: 2 MB), categorized as an Officer Change event, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific details on the officer position affected, appointment or resignation, reasons for change, financial metrics, period-over-period comparisons, or quantitative data are explicitly stated in the provided filing information. Sector is not specified, and no positive or negative performance indicators are mentioned.

30-01-2026

Coya Therapeutics, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-030531), reporting multiple items: Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). This multi-item filing signals potentially significant developments, but no specific transaction details, financial metrics, dollar values, share counts, or impacts are disclosed in the provided information. No positive or negative quantitative metrics are available for balanced comparison.

30-01-2026

Horizon Space Acquisition II Corp. filed an 8-K on 2026-01-30 disclosing other events under Item 8.01 and financial statements/exhibits under Item 9.01 in connection with a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, synergies, regulatory pathway, or shareholder impacts are provided in the filing summary. No quantitative metrics, positive or negative performance indicators, or scheduled events are mentioned.

30-01-2026

Amgen Inc filed an 8-K on January 30, 2026, disclosing under Item 1.02 the termination of a material definitive agreement. Item 9.01 provides financial statements and exhibits. No specific details on the agreement, parties, financial impacts, or quantitative metrics are disclosed.

30-01-2026

Enzon Pharmaceuticals, Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.03 material modifications to rights of security holders. Item 9.01 discloses financial statements and exhibits. No quantitative details, transaction values, or specific impacts are provided in the filing summary.

30-01-2026

ProMIS Neurosciences Inc. filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. While the material agreement may represent a strategic development, the unregistered equity sales could imply potential shareholder dilution. No specific transaction details, financial impacts, or quantitative metrics are disclosed.

30-01-2026

Akebia Therapeutics, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on transaction terms, financial impacts, or personnel changes are provided.

30-01-2026

Edible Garden AG Inc filed a Form 8-K on January 30, 2026 (AccNo: 0001477932-26-000522), reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing indicates governance and shareholder rights changes, but specific details on modifications, amendments, events, or exhibits are NOT_DISCLOSED. No quantitative financial impacts, positive or negative metrics, or directional biases are provided.

30-01-2026

ALX Oncology Holdings Inc filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-030579), reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, events, transaction size, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

30-01-2026

HERC Holdings Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), whether it was an appointment or resignation, reasons for the change (e.g., retirement, performance), internal/external status, timing, board composition impact, or any financial metrics were disclosed. This appears to be a routine governance disclosure with no quantified impacts provided.

30-01-2026

Wolfspeed, Inc. filed an 8-K on January 30, 2026, reporting under Item 5.02 regarding departure of directors or certain officers, election/appointment of directors/officers, and compensatory arrangements; Item 3.02 on unregistered sales of equity securities; Item 8.01 other events; and Item 9.01 financial statements/exhibits. No specific details on the officer change—including key position, appointment/resignation status, reasons, or timing—are disclosed. No quantitative metrics, financial data, named individuals, or scheduled events are mentioned.

30-01-2026

BKV Corp filed an 8-K on 2026-01-30 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. The filing also covers unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific parties, deal terms, financial metrics, positive or negative performance indicators, or quantitative data are disclosed in the provided filing information.

30-01-2026

Illumina, Inc. filed an 8-K on January 30, 2026, announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes other events under Item 8.01 and financial statements and exhibits under Item 9.01. No specific transaction details, parties, values, financial metrics, or performance comparisons are disclosed.

30-01-2026

Nuwellis, Inc. filed a multi-item Form 8-K on January 30, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departures/elections/appointments of directors/officers and compensatory arrangements (Item 5.02), and Regulation FD disclosure (Item 7.01). No quantitative financial metrics, transaction values, share counts, or specific impacts are disclosed. The filing includes exhibits under Item 9.01.

30-01-2026

SM Energy Co filed an 8-K on 2026-01-30 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), amendments to articles of incorporation or bylaws and/or change in fiscal year (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No quantitative deal terms, parties involved, or financial impacts were explicitly stated.

30-01-2026

STANDARD BIOTOOLS INC. filed an 8-K on January 30, 2026 (AccNo: 0001104659-26-008375), announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also discloses results of operations and financial condition (Item 2.02) and Regulation FD disclosure (Item 7.01), with financial statements and exhibits attached under Item 9.01. No specific transaction details, financial metrics, parties involved, or quantitative impacts are disclosed.

30-01-2026

OptimumBank Holdings, Inc. filed an 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No specific details, dollar values, share counts, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing signaling potentially significant corporate actions, but lacks quantitative data for assessment.

30-01-2026

Spark I Acquisition Corp filed an 8-K on January 30, 2026 (AccNo: 0001104659-26-008449), under Item 3.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. No quantitative financial metrics, transaction details, deal structure, parties involved, valuations, synergies, regulatory pathways, or shareholder impacts are mentioned. Sector is not specified, and no positive or comparative performance data is provided.

30-01-2026

Cullen/Frost Bankers, Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason, timing, or any quantitative data are disclosed in the provided filing summary.

30-01-2026

International Endeavors Corp filed a Form 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement's nature, parties, terms, or financial impacts provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

30-01-2026

Sky Century Investment, Inc. filed an 8-K on January 30, 2026, reporting material modifications to rights of security holders under Item 3.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the nature of the modifications, events, or exhibits provided. No quantitative financial metrics, impacts, or comparisons are disclosed.

30-01-2026

SmartKem, Inc. filed an 8-K on 2026-01-30 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No quantitative details, transaction terms, financial impacts, or other metrics are provided in the filing summary. This represents a multi-item mandatory disclosure with limited specifics available.

30-01-2026

Caro Holdings Inc. filed an 8-K on January 30, 2026 (AccNo: 0001640334-26-000176, Size: 121 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data such as compensation are disclosed. Sector is NOT_DISCLOSED.

• ·Event date: January 30, 2026
• ·Source: us_sec

30-01-2026

International Land Alliance Inc. filed a Form 8-K on January 30, 2026, reporting multiple material events under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 3.02 (Unregistered Sales of Equity Securities), with Item 9.01 listing Financial Statements and Exhibits. No quantitative details such as transaction values, share counts, or financial impacts are disclosed in the provided information. This multi-item filing signals potentially significant corporate actions but lacks specifics on positive or negative implications.

• ·Multi-item 8-K filing indicating mandatory disclosures for material agreement, financial obligation, and equity securities sales
• ·AccNo: 0001493152-26-004441, Size: 432 KB
• ·Sector: NOT_DISCLOSED

30-01-2026

Cincinnati Financial Corp filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

30-01-2026

NRG Energy, Inc. filed an 8-K on January 30, 2026, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also includes creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific deal terms, parties, values, positives, negatives, or metrics were disclosed.

30-01-2026

FG Imperii Acquisition Corp. filed an 8-K on 2026-01-30 disclosing entry into a material definitive agreement under Item 1.01. Item 9.01 provides financial statements and exhibits. No quantitative metrics, transaction details, parties, valuation, or performance comparisons (positive, negative, or flat) are disclosed in the provided filing summary.

30-01-2026

Power Integrations Inc filed an 8-K on 2026-01-30 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers; under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year; and under Item 9.01 financial statements and exhibits. No specific details such as names, positions, reasons for changes, or quantitative impacts are disclosed. No positive or negative metrics are provided in the filing summary.

30-01-2026

Mondelez International, Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative impacts were disclosed.

30-01-2026

PEOPLES FINANCIAL SERVICES CORP. filed an 8-K on January 30, 2026, disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or any quantitative metrics are disclosed.

30-01-2026

Surrozen, Inc./DE filed an 8-K on 2026-01-30 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details, names, reasons, timing, or financial terms are provided in the filing summary. Sector not specified.

30-01-2026

Kelly Services Inc filed a multi-item Form 8-K on January 30, 2026 (AccNo: 0001193125-26-031768), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.01 (Changes in Control of Registrant), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, named parties, quantitative metrics, or period-over-period comparisons are disclosed in the provided filing information.

30-01-2026

INVO Fertility, Inc. filed a multi-item Form 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, alongside other events (Item 8.01) and exhibits (Item 9.01). While the material agreement suggests potential strategic developments, the unregistered equity sales indicate possible shareholder dilution. No specific transaction details, financial metrics, or dollar values were disclosed.

30-01-2026

Olema Pharmaceuticals, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. Specific details such as the affected officer's name, position, whether it was an appointment or resignation, reasons, or effective date are NOT_DISCLOSED.

30-01-2026

Genasys Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or financial terms are disclosed in the provided filing summary. No quantitative metrics, performance comparisons, or additional context provided.

30-01-2026

BranchOut Food Inc. filed a Form 8-K on January 30, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing covering a new agreement, financial results, and new financial obligations, but specific transaction details, dollar values, financial metrics, or performance comparisons are NOT_DISCLOSED. No positive or negative metrics, period-over-period changes, or guidance revisions are provided in the available information.

30-01-2026

Athena Technology Acquisition Corp. II filed an 8-K on January 30, 2026, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) in connection with a merger/acquisition event. No quantitative metrics, deal structure details, parties involved, strategic rationale, or financial impacts were explicitly disclosed in the provided filing summary. Sector remains unspecified.

30-01-2026

Beeline Holdings, Inc. filed an 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 discloses financial statements and exhibits. No quantitative financial metrics, transaction values, or performance comparisons are provided in the filing summary.

30-01-2026

Yellowstone Midco Holdings II, LLC filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 financial statements and exhibits. No quantitative financial metrics, transaction values, named individuals, or specific details on the events were disclosed. This multi-item filing indicates significant governance and contractual changes without disclosed positive or negative impacts.

• ·Multi-item mandatory 8-K filing covering governance changes and a material agreement.
• ·No revenue, earnings, balance sheet effects, guidance, or dollar values disclosed.
• ·Critical missing information: Specific details of the material definitive agreement, identities of departing/appointed directors/officers, nature of rights modifications or amendments, any financial exhibits content, dollar value or size of transaction, period-over-period metrics. Analysis confidence: LOW (<50% key data available).

30-01-2026

Design Therapeutics, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-031772), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, or impacts are disclosed. Sector is NOT_DISCLOSED.

30-01-2026

Generation Income Properties, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, dollar impacts, or additional details such as reasons for delisting, balance sheet effects, or guidance changes are disclosed.

30-01-2026

Direct Digital Holdings, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.

30-01-2026

Dollar Tree, Inc. filed an 8-K on January 30, 2026 (AccNo: 0000935703-26-000017), disclosing developments under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, nature of changes (appointment or resignation), reasons, or any quantitative impacts are disclosed. This appears to be a routine governance disclosure with no additional financial or operational metrics provided.

30-01-2026

TuHURA Biosciences, Inc./NV filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-031742), under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No quantitative financial metrics, positive developments, or additional details such as reasons, impacts, or timelines were disclosed. This represents a material negative event with no offsetting positives mentioned.

• ·Filing size: 167 KB
• ·Sector: not specified

30-01-2026

Becton Dickinson & Co filed a Form 8-K on January 30, 2026, disclosing matters under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also covers Item 5.07 on submission of matters to a vote of security holders and Item 9.01 on financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, voting outcomes, or exhibits are disclosed in the provided information.

30-01-2026

Microvision, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001493152-26-004505), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, quantitative metrics, or other data explicitly stated. No positive, negative, or flat performance metrics are disclosed.

30-01-2026

NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP /DC/ filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, events, transaction size, parties, financial impacts, or metrics disclosed in the provided information. No positive or negative quantitative changes are mentioned.

30-01-2026

Solo Brands, Inc. filed an 8-K on 2026-01-30 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for changes, or any financial metrics are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

30-01-2026

Space Asset Acquisition Corp. filed an 8-K on January 30, 2026 (AccNo: 0001213900-26-010205), disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition. Additional items include unregistered sales of equity securities (Item 3.02), departures/elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative metrics, deal terms, parties, or performance data are disclosed.

30-01-2026

PEDEVCO CORP filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, timing, or compensation arrangements are provided. No quantitative financial metrics, performance comparisons, or other material data are mentioned.

30-01-2026

X3 Acquisition Corp. Ltd. filed an 8-K on 2026-01-30 disclosing unregistered sales of equity securities under Item 3.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative metrics, deal details, parties involved, valuations, synergies, regulatory pathways, or shareholder impacts are explicitly stated in the provided filing summary. Sector is not specified.

30-01-2026

Esquire Financial Holdings, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons for change, timing, or financial metrics are disclosed.

30-01-2026

FIRST ADVANTAGE CORP filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-031830, Size: 150 KB), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed. Sector is not specified.

30-01-2026

Marchex Inc filed an 8-K on 2026-01-30 disclosing Item 1.01 Entry into a Material Definitive Agreement alongside Item 5.02 regarding Departure of Directors or Certain Officers, Election of Directors, Appointment of Certain Officers, and Compensatory Arrangements of Certain Officers. This is a multi-item filing with no specific details on the agreement terms, personnel involved, or financial implications provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

30-01-2026

OPENLANE, Inc. filed a Form 8-K on January 30, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, appointment or resignation status, reasons for the change, timing, or individuals involved are disclosed. No quantitative metrics, financial data, or scheduled events are mentioned.

30-01-2026

Dragonfly Energy Holdings Corp. filed an 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and attaching financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, parties, or financial impacts are disclosed. This is a multi-item filing focused on a material event with no quantitative metrics provided.

30-01-2026

Zillow Group, Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No quantitative details such as transaction value, financial terms, or impact on revenue, earnings, or balance sheet were disclosed. This is a multi-item mandatory filing with no additional metrics, guidance changes, or scheduled events mentioned.

30-01-2026

Velocity Financial, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 8.01 other events, with Item 9.01 listing financial statements and exhibits. No specific details on the agreement, events, dollar values, financial impacts, or performance metrics are disclosed in the provided filing summary. No positive or negative metrics, period-over-period comparisons, or quantitative data are mentioned.

30-01-2026

Intuit Inc. filed an 8-K on January 30, 2026 (AccNo: 0000896878-26-000008, Size: 887 KB), disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, terms, strategic context, or financial metrics are disclosed in the provided filing summary.

30-01-2026

VYNE Therapeutics Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, parties, financial impacts, or quantitative metrics are provided in the filing summary.

30-01-2026

Laird Superfood, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details, dollar values, personnel names, or financial impacts are disclosed.

30-01-2026

Strawberry Fields REIT, Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, or effective date are disclosed.

30-01-2026

Praetorian Acquisition Corp. filed an 8-K on 2026-01-30 disclosing a merger/acquisition event under Item 8.01 Other Events, with Item 9.01 providing financial statements and exhibits. No specific deal structure, parties involved, valuation, strategic rationale, or quantitative metrics are disclosed in the filing summary. The announcement is informational without detailed terms or impacts.

• ·Filing Accession Number: 0001213900-26-010243
• ·Filing Size: 409 KB
• ·Sector: NOT_DISCLOSED

30-01-2026

Walmart Inc. filed an 8-K on 2026-01-30 under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors or certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are disclosed. No positive or negative metrics are provided in the filing summary.

30-01-2026

AXIS Capital Holdings Ltd filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are provided in the filing summary. This is a standard governance disclosure with no indicated positive or negative performance metrics.

30-01-2026

Expion360 Inc. filed a Form 8-K on 2026-01-30 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, positive developments, dollar values, or reasons for the delisting were disclosed. This represents a material negative event with no offsetting positives mentioned.

• ·Accession Number: 0001903596-26-000022
• ·Filing size: 202 KB
• ·Sector: NOT_DISCLOSED

30-01-2026

GigCapital9 Corp. filed a Form 8-K on January 30, 2026, disclosing multiple events including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departures or appointments of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03), along with other events (Item 8.01) and exhibits (Item 9.01). No specific transaction details, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This multi-item filing signals potential strategic, governance, and capital structure changes, but lacks details to assess directionality.

30-01-2026

Lafayette Digital Acquisition Corp. I filed an 8-K on January 30, 2026 (AccNo: 0001213900-26-010254), disclosing an other event under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. No specific details on parties, deal structure, valuation, financial metrics, synergies, regulatory pathway, or shareholder impacts are provided. Sector is not specified, and no quantitative data or scheduled events are mentioned.

• ·File size: 266 KB

30-01-2026

AB International Group Corp. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. Item 9.01 provides financial statements and exhibits. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons are disclosed.

30-01-2026

Byrna Technologies Inc. filed an 8-K on 2026-01-30 (AccNo: 0001437749-26-002563) under Item 5.02 disclosing departure of directors or certain officers; election of directors; appointment of certain officers; and compensatory arrangements of certain officers. No specific details on key positions affected (e.g., CEO, CFO), whether appointment or resignation, reasons for change, internal/external status, timing, or any quantitative data such as compensation amounts are disclosed. No board meeting outcomes, succession signals, financial metrics, or scheduled events mentioned.

30-01-2026

USCB Financial Holdings, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed.

30-01-2026

IMAC Holdings, Inc. filed an 8-K on 2026-01-30 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or impacts provided. No positive or negative financial metrics, comparisons, or guidance changes are mentioned.

30-01-2026

International Business Machines Corp (IBM) filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, timing, or any quantitative impacts are disclosed.

30-01-2026

Quetta Acquisition Corp filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a new material definitive agreement and under Item 1.02 termination of a prior material definitive agreement, signaling a pivot in merger/acquisition strategy. No quantitative metrics, deal values, parties involved, or financial impacts are disclosed, resulting in mixed implications with no clear positive or negative dominance. Sector details are not specified.

30-01-2026

Arrive AI Inc. filed an 8-K on January 30, 2026, reporting Item 1.01 Entry into a Material Definitive Agreement and Item 3.02 Unregistered Sales of Equity Securities, with Item 9.01 Financial Statements and Exhibits. No specific transaction details, dollar values, parties, strategic rationale, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

30-01-2026

FUSE GROUP HOLDING INC. filed an 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No specific transaction details, dollar values, strategic context, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

30-01-2026

NanoVibronix, Inc. filed a Form 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 3.03 material modifications to rights of security holders, and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction values, financial impacts, or specific terms are disclosed in the provided filing summary.

30-01-2026

Chevron Corp filed an 8-K on January 30, 2026 (AccNo: 0000093410-26-000021), under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, effective dates, or any quantitative impacts are disclosed in the provided filing summary. This appears to be a routine governance disclosure without further elaboration.

30-01-2026

Legato Merger Corp. IV filed an 8-K on 2026-01-30 (AccNo: 0001829126-26-000821) disclosing Item 3.02 Unregistered Sales of Equity Securities, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, synergies, regulatory details, or shareholder impacts are mentioned. Sector is not specified, and no quantitative data or comparisons are provided.

30-01-2026

Rithm Acquisition Corp. filed an 8-K on 2026-01-30 disclosing Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 includes Financial Statements and Exhibits. No quantitative metrics, transaction details, or period-over-period comparisons are mentioned.

30-01-2026

PennantPark Investment Corp filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction values, or impacts are disclosed in the provided filing summary.

30-01-2026

Marquie Group, Inc. filed an 8-K on 2026-01-30 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data were provided in the filing summary. No positive or negative metrics were mentioned.

30-01-2026

IO Biotech, Inc. filed an 8-K on January 30, 2026, disclosing costs associated with exit or disposal activities under Item 2.05, departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on leadership changes, reasons, costs, or metrics are disclosed in the provided information.

30-01-2026

Comstock Inc. filed an 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, alongside Regulation FD disclosure under Item 7.01 and exhibits under Item 9.01. No specific transaction details, dollar values, share counts, or financial impacts are disclosed in the provided filing summary. This multi-item filing signals potentially strategic developments but also possible dilution from equity sales.

30-01-2026

Tenaya Therapeutics, Inc. filed an 8-K on 2026-01-30 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, which is a material negative event signaling potential loss of exchange listing and reduced liquidity. Item 5.02 discloses departures of directors or certain officers, elections, appointments, or compensatory arrangements, with unspecified direction that could indicate leadership changes but lacks positive or negative details. Item 9.01 includes financial statements and exhibits, providing additional context without specified metrics.

30-01-2026

Saratoga Investment Corp. filed a Form 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, terms, positive or negative impacts, or other metrics are provided in the filing summary.

30-01-2026

EQV Ventures Acquisition Corp. filed an SEC document on 2026-01-30 (AccNo: 0001213900-26-010279, Size: 48 MB) related to a Merger/Acquisition event. No specific details on parties, deal structure, valuation, financial terms, synergies, regulatory pathway, shareholder impacts, or market implications are disclosed in the provided metadata. Sector is not specified, limiting assessment of strategic rationale or sector effects.

30-01-2026

Aspire Biopharma Holdings, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004543), reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. This constitutes a multi-item mandatory disclosure with no quantitative details on transaction values, share counts, or financial impacts provided. No positive or negative metrics are disclosed.

30-01-2026

Stardust Power Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, or any quantitative data are NOT_DISCLOSED. No positive or negative metrics, board outcomes, or governance implications are specified.

30-01-2026

OFF THE HOOK YS INC. filed an 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, or quantitative details were provided in the filing summary. No financial metrics, performance comparisons, or other material data disclosed.

30-01-2026

Spero Therapeutics, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on affected positions, individuals, reasons for change, or timing are disclosed. No quantitative metrics or financial impacts are mentioned.

30-01-2026

NEXGEL, INC. filed an 8-K on 2026-01-30 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references attached financial statements and exhibits. No specific details on positions affected, individuals, reasons, timing, or compensation are disclosed.

30-01-2026

ASP Isotopes Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement. No specific details on the agreement's terms, parties, value, or financial impact are disclosed in the available filing summary. No quantitative metrics, comparisons, or other items are mentioned.

30-01-2026

Aspira Women's Health Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 lists financial statements and exhibits. No specific transaction details, dollar values, financial metrics, or performance comparisons are disclosed.

30-01-2026

Blink Charging Co. filed a Form 8-K on 2026-01-30 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. Item 9.01 covers financial statements and exhibits. No financial metrics, transaction values, or specific reasons for the delisting event were disclosed.

• ·Accession Number: 0001493152-26-004537
• ·Filing size: 205 KB
• ·Sector: not specified

30-01-2026

Madrigal Pharmaceuticals, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details, financial terms, impacts, or quantitative metrics are disclosed in the provided filing summary.

30-01-2026

urban-gro, Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, alongside Item 5.07 on submission of matters to a vote of security holders and Item 9.01 for financial statements and exhibits. No specific details on positions affected, reasons for changes, vote outcomes, or exhibit contents are disclosed. No quantitative financial metrics, performance comparisons, or directional indicators provided.

30-01-2026

NN Inc filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, with Item 9.01 providing financial statements and exhibits. No specific details, dollar values, strategic context, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no quantitative metrics or performance comparisons available.

30-01-2026

Ondas Holdings Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation status, reasons, timing, or individuals involved are provided. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

30-01-2026

DocGo Inc. filed an 8-K on January 30, 2026, under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No additional details on the specific reason, financial impacts, or strategic implications are disclosed. This event signals potential liquidity and visibility challenges for shareholders.

30-01-2026

Helix Acquisition Corp. III filed an 8-K on 2026-01-30 (AccNo: 0001213900-26-010350) disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. No specific deal structure, parties involved, valuation, financial terms, synergies, regulatory pathways, or shareholder impacts are detailed in the filing summary. No quantitative metrics, comparisons, or scheduled events are mentioned.

30-01-2026

Mountain Lake Acquisition Corp. II filed an 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, with financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, parties, or performance comparisons are disclosed. Sector is not specified.

30-01-2026

Safe & Green Development Corp filed a Form 8-K on January 30, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No positive financial metrics, growth indicators, or offsetting developments were disclosed. This event signals significant regulatory or compliance issues impacting stock market access.